RxDoctor Payments Data

Amir Chaudhari, DO

Clinical Cardiac Electrophysiology · Waukesha, WINPI 1679858567

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.5%), grants and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 35.1% of the total. Reporting peaked in 2019 at $8,844 and has fallen 93.5% since, to $573 in 2025.

$16,286in general payments, 2019–2025

Across 117 payments — averaging $139.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Boston Scientific$5K
  • Medtronic$5K
  • Medical Device Business Services, Inc.$145
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$26
  • Cardiva Medical, Inc.$24
  • plus $84 from 4 others

What the payments were for

  • Consulting fees$6504%
  • Grants$3,75023%
  • Travel & lodging$8,54352%
  • Food & beverage$3,12119%
  • Education$2221%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,286 in reported general payments places this provider in the 55th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$202,283
Medicare patients
691
Services billed
2,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban893$837,451
XareltoRivaroxaban209$209,924
Dofetilide336$36,163
Ranolazine ErRanolazine345$28,167
Mexiletine Hcl108$9,905
Diltiazem 24hr Er (Cd)Diltiazem Hcl244$7,925
Dabigatran EtexilateDabigatran Etexilate Mesylate25$7,903
Metoprolol Succinate520$6,519
Flecainide Acetate171$5,756
Amiodarone Hcl315$3,291
SotalolSotalol Hcl106$2,437
Enoxaparin Sodium12$1,250
Diltiazem 24hr ErDiltiazem Hcl26$956
Dilt-XrDiltiazem Hcl14$875
Nadolol24$864

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Waukesha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →